Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Evaluating the risks of clinical research.

Rid A, Emanuel EJ, Wendler D.

JAMA. 2010 Oct 6;304(13):1472-9. doi: 10.1001/jama.2010.1414. Erratum in: JAMA. 2010 Dec 8;304(22):2484.

PMID:
20924013
[PubMed - indexed for MEDLINE]
2.

Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.

Bacchetti P, Boylan RD, Terrault NA, Monto A, Berenguer M.

Int J Biostat. 2010 Feb 20;6(1):Article 7. doi: 10.2202/1557-4679.1213.

PMID:
20305705
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Estimating complex multi-state misclassification rates for biopsy-measured liver fibrosis in patients with hepatitis C.

Bacchetti P, Boylan R.

Int J Biostat. 2009;5(1):Article 5. doi: 10.2202/1557-4679.1139.

PMID:
20104258
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH; VIRAHEP-C Study Group.

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1403-11. doi: 10.1016/j.cgh.2008.08.006. Epub 2008 Aug 19.

PMID:
19081528
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Exceeding the limits of liver histology markers.

Mehta SH, Lau B, Afdhal NH, Thomas DL.

J Hepatol. 2009 Jan;50(1):36-41. doi: 10.1016/j.jhep.2008.07.039. Epub 2008 Oct 18.

PMID:
19012989
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Estimation of HIV incidence in the United States.

Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS; HIV Incidence Surveillance Group.

JAMA. 2008 Aug 6;300(5):520-9. doi: 10.1001/jama.300.5.520.

PMID:
18677024
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Diagnosis and quantitation of fibrosis.

Manning DS, Afdhal NH.

Gastroenterology. 2008 May;134(6):1670-81. doi: 10.1053/j.gastro.2008.03.001. Review.

PMID:
18471546
[PubMed - indexed for MEDLINE]
8.

Non-invasive markers for the prediction of fibrosis in chronic hepatitis C infection.

Cross T, Antoniades C, Harrison P.

Hepatol Res. 2008 Aug;38(8):762-9. doi: 10.1111/j.1872-034X.2008.00364.x. Epub 2008 May 7.

PMID:
18462378
[PubMed]
9.

Influence of cannabis use on severity of hepatitis C disease.

Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA.

Clin Gastroenterol Hepatol. 2008 Jan;6(1):69-75. doi: 10.1016/j.cgh.2007.10.021.

PMID:
18166478
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression.

Bacchetti P, Tien PC, Seaberg EC, O'Brien TR, Augenbraun MH, Kral AH, Busch MP, Edlin BR.

BMC Infect Dis. 2007 Dec 10;7:145.

PMID:
18070362
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Using the outcome for imputation of missing predictor values was preferred.

Moons KG, Donders RA, Stijnen T, Harrell FE Jr.

J Clin Epidemiol. 2006 Oct;59(10):1092-101. Epub 2006 Jun 19.

PMID:
16980150
[PubMed - indexed for MEDLINE]
12.

Global challenges in liver disease.

Williams R.

Hepatology. 2006 Sep;44(3):521-6. Review.

PMID:
16941687
[PubMed - indexed for MEDLINE]
13.

The survival benefits of AIDS treatment in the United States.

Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA.

J Infect Dis. 2006 Jul 1;194(1):11-9. Epub 2006 Jun 1.

PMID:
16741877
[PubMed - indexed for MEDLINE]
Free Article
14.

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ.

Ann Intern Med. 2006 May 16;144(10):705-14.

PMID:
16702586
[PubMed - indexed for MEDLINE]
15.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
[PubMed - indexed for MEDLINE]
16.

Risks of a range of alcohol intake on hepatitis C-related fibrosis.

Monto A, Patel K, Bostrom A, Pianko S, Pockros P, McHutchison JG, Wright TL.

Hepatology. 2004 Mar;39(3):826-34.

PMID:
14999703
[PubMed - indexed for MEDLINE]
17.

Age and variant Creutzfeldt-Jakob disease.

Bacchetti P.

Emerg Infect Dis. 2003 Dec;9(12):1611-2.

PMID:
14720404
[PubMed - indexed for MEDLINE]
Free Article
18.

Hepatitis C in the HIV-Infected Person.

Sulkowski MS, Thomas DL.

Ann Intern Med. 2003 Feb 4;138(3):197-207. Review.

PMID:
12558359
[PubMed - indexed for MEDLINE]
19.

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users.

Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL.

Hepatology. 2002 May;35(5):1247-55.

PMID:
11981775
[PubMed - indexed for MEDLINE]
20.

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model.

Deuffic-Burban S, Poynard T, Valleron AJ.

J Viral Hepat. 2002 Mar;9(2):114-22.

PMID:
11876793
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk